<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02704182</url>
  </required_header>
  <id_info>
    <org_study_id>tDCS in TKA</org_study_id>
    <nct_id>NCT02704182</nct_id>
  </id_info>
  <brief_title>Transcranial Direct Current Stimulation for Postoperative Pain in Knee Arthroplasty</brief_title>
  <acronym>TDCSTKA</acronym>
  <official_title>Role of Transcranial Direct Current Stimulation (tDCS) in Reduction of Pain and Postsurgical Opioid Consumption in Total Knee Arthroplasty (TKA)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to detect the effect of trans-cranial direct current&#xD;
      stimulation on postoperative pain and opioid consumption in total knee arthro-plasty&#xD;
      patients. Fifty patients undergoing unilateral TKA will be randomly assigned to receive 4&#xD;
      sessions, total of 80 minutes of real (n=25) or sham tDCS (n=25). Stimulation will be given&#xD;
      on 4 consecutive postoperative days, group 1 will receive real stimulation with the active&#xD;
      electrode over the leg representation of the motor strip (cortical motor area of the leg) and&#xD;
      the reference electrode over the arm, group 2 will receive Sham tDCS. Pain level will be&#xD;
      evaluated according to visual analogue scale (VAS) and LANSS pain scale before (base line)&#xD;
      after 1st, 2nd, 3rd and 4th sessions.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study aims to to detect the effect of trans-cranial direct current stimulation on&#xD;
      postoperative pain and opioid consumption in total knee arthro-plasty patients.&#xD;
&#xD;
      Fifty patients undergoing unilateral TKA will be randomly assigned to receive 4 sessions,&#xD;
      total of 80 minutes of real (n=25) or sham tDCS (n=25). Stimulation will be given on 4&#xD;
      consecutive postoperative days, group 1 will receive real stimulation with the active&#xD;
      electrode over the leg representation of the motor strip (cortical motor area of the leg) and&#xD;
      the reference electrode over the arm, group 2 will receive Sham tDCS.&#xD;
&#xD;
      Pain level will be evaluated according to visual analogue scale (VAS) and LANSS pain scale&#xD;
      before (baseline) after 1st, 2nd, 3rd and 4th sessions.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2015</start_date>
  <completion_date type="Actual">January 2016</completion_date>
  <primary_completion_date type="Actual">January 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Opioids consumption per 24 hours at the 4th day postoperative</measure>
    <time_frame>day 4 postoperative</time_frame>
    <description>Measuring the consumption dose of opioids per 24 hours at the fourth day</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Opioids consumption / 24 hours at the third day postoperative</measure>
    <time_frame>day 3 postoperative</time_frame>
    <description>Measuring the consumption dose of opioids per 24 hours at the third day postoperative</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Opioids Consumption / 24 hours at the second day postoperative</measure>
    <time_frame>day 2 postoperative</time_frame>
    <description>Measuring the consumption dose of opioids per 24 hours at the second day post-operative</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Opioids consumption / 24 hours at the 1st day postoperative</measure>
    <time_frame>1st day postoperative</time_frame>
    <description>Measuring the consumption dose of opioids per 24 hours at the 1st day postoperative</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Opioid side effects</measure>
    <time_frame>4th post operative day</time_frame>
    <description>Record Opioid-related adverse effects (nausea and/or vomiting and the need for alizapride 50mg IV).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain assessment by VAS</measure>
    <time_frame>3rd postoperative day</time_frame>
    <description>Pain Assessment using Visual Analogue Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain assessment by VAS</measure>
    <time_frame>2nd postoperative day</time_frame>
    <description>Pain Assessment using Visual Analogue Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain assessment by VAS</measure>
    <time_frame>1st postoperative days</time_frame>
    <description>Pain Assessment using Visual Analogue Scale</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">46</enrollment>
  <condition>Knee Replacement</condition>
  <arm_group>
    <arm_group_label>Real tDCS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Direct current stimulation using anodal electrode, 25 patients received real anodal tDCS on the motor area for 20 minutes every day for 4 consecutive days.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham tDCS</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Sham direct current stimulation, 25 patients received sham anodal tDCS on the motor area for 20 minutes every day for 4 consecutive days.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>tDCS</intervention_name>
    <description>25 patients received real anodal tDCS on the motor area for 20 minutes every day for 4 consecutive days.</description>
    <arm_group_label>Real tDCS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sham tDCS</intervention_name>
    <description>25 patients received sham anodal tDCS on the motor area for 20 minutes every day for 4 consecutive days.</description>
    <arm_group_label>Sham tDCS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Providing informed consent to participate in the study.&#xD;
&#xD;
          2. age &gt;30 years and &lt;60 years both genders.&#xD;
&#xD;
          3. ASA I to II patients.&#xD;
&#xD;
          4. postoperative unilateral total knee arthroplasty.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Contraindications to transcranial brain stimulation: presence of a history of&#xD;
             epilepsy, implantable devices (ventriculo-peritoneal shunts, pacemakers, intracranial&#xD;
             metal implants).&#xD;
&#xD;
          2. Neurological or psychiatric pathology.&#xD;
&#xD;
          3. Patients taking major centrally acting drugs (anti-epileptics or antidepressants) or&#xD;
             high-dose opioid.&#xD;
&#xD;
          4. History of substance abuse.&#xD;
&#xD;
          5. Severe cardio-pulmonary, renal, hepatic diseases.&#xD;
&#xD;
          6. Pregnancy and lactation.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>January 31, 2016</study_first_submitted>
  <study_first_submitted_qc>March 8, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 9, 2016</study_first_posted>
  <last_update_submitted>September 12, 2020</last_update_submitted>
  <last_update_submitted_qc>September 12, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 16, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Eman M. Khedr</investigator_full_name>
    <investigator_title>Clinical Professor</investigator_title>
  </responsible_party>
  <keyword>Arthroplasties, Knee Replacement</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

